Progress in Immunology Vol
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Paul Ehrlich Institute - Centre of Excellence for Vaccines, Blood Products and Emerging Therapies
The Paul Ehrlich Institute - Centre of Excellence for Vaccines, Blood Products and Emerging Therapies Johannes Löwer and co-workers 8th DGRA Annual Congress Bonn, 9 and 10 May 2006 www.pei.de PEI Paul Ehrlich 1896 PEI Potency of Anti-D Immunoglobulin Correlation between PEI’s and Manufacturer’s Results 1800 A A A A A A A AA A Measurement C C C B B C CC C C 600 900 1200 1500 PEI 600 900 1200 1500 1800 Manufacturer History 1896 Institute for Serum Research and Serum Examination, Berlin-Steglitz 1899 Royal Institute for Experimental Therapy, Frankfurt/Main 1947 Paul-Ehrlich-Institut - State Institute for Experimental Therapy, Frankfurt/Main 1972 Paul-Ehrlich-Institut, Federal Agency for Sera and Vaccines, Frankfurt/Main 1990 Paul-Ehrlich-Institut, Federal Agency for Sera and Vaccines, Langen/Hessen PEI PEI: Areas of Responsibility • Vaccines (human, veterinary) • Sera, immunoglobulins, monoclonal antibodies • Allergens (diagnostic, therapeutic) • Blood products (plasma derived, recombinant) • Blood components for transfusion • Gene transfer products • Cell therapy products (somatic, xenogeneic) • Tissues • (Engineered tissues) PEI PEI: Areas of Responsibility • Vaccines (human, veterinary) • Sera, immunoglobulins, monoclonal antibodies • Allergens (diagnostic, therapeutic) • Blood products (plasma derived, recombinant) • Blood components for transfusion • Gene transfer products • Cell therapy products (somatic, xenogeneic) • Tissues • (Engineered tissues) PEI Royal Institute of Experimental Medicine PEI: Duties • Official batch release • -
The Interdisciplinary Center Herzliya
המרכז הבינתחומי הרצליה The Interdisciplinary Center Herzliya The Interdisciplinary Center (IDC) Herzliya pays tribute to המרכז הבינתחומי הרצליה חולק כבוד ל־ MICHAEL SELA מיכאל סלע .Professor Michael Sela of the Weizmann Institute of Science is a world renowned immunologist פרופ' מיכאל סלע ממכון ויצמן למדע הוא מדען בעל שם עולמי בתחום האימונולוגיה )חקר מערכת His groundbreaking research has most notably led to the development of Copaxone, a drug used החיסון(. מחקריו פורצי הדרך, ובראשם פיתוח תרופת הקופקסון לטיפול בטרשת נפוצה, הקלו על .to treat multiple sclerosis that has helped ease the suffering of millions of patients worldwide חייהם של מיליוני חולים ברחבי העולם. Born in Poland in 1924, Prof. Sela earned his Bachelor and Master of Science degrees פרופ' מיכאל סלע, שנולד בפולין בשנת 1924, למד את התואר הראשון והשני במחלקה לכימיה from the School of Chemistry at the Hebrew University of Jerusalem, prior to focusing on life באוניברסיטה העברית בירושלים לפני שבחר לעסוק בתחום מדעי החיים. בשנת 1946, בעת שיצא sciences. In 1946, while studying in Switzerland, he assisted the Aliyah Bet’s efforts to help ללימודים בשווייץ, הוא פעל בשירות ההעפלה באיטליה. עם הקמת המדינה, הוא שימש כנספח Jews immigrate. After Israel’s inception, Prof. Sela, who is fluent in nine languages, served as מסחרי בצירות ישראל בצ'כוסלובקיה. צ'כית, למי שאינו יודע, היא רק אחת מבין תשע שפות שבהן .the commercial attaché at the Israeli mission to Czechoslovakia הוא שולט. After his return to Israel in 1950, Prof. Sela made the Weizmann Institute of Science his כאשר שב לארץ בשנת 1950, החל פרופ' מיכאל סלע את דרכו המחקרית במכון ויצמן למדע academic home. -
Xii World Asthma, Allergy & Copd Forum
XII WORLD ASTHMA, ALLERGY & COPD FORUM Saint Petersburg, Russia June 29–July 2, 2019 SAINT PETERSBURG SAINT PROGRAM World Immunopathology XIII WORLD ASTHMA, Organization (WIPO) ALLERGY & COPD FORUM Saint-Petersburg, Russia July 2–5, 2020 General Information St. Pet The World Immunopathology Organization (WIPO) is a professional, non-profit organization. WIPO was created in December 2002, at the I World Congress on Immunopathology in Singapore. During these years, WIPO successfully organized many international congresses and regional and national meetings throughout See you in Saint Petersburg in 2020! the world all promoting basic and clinical research and giving an opportunity for exchanging ideas. WIPO is aimed at collecting and disseminating scientific information and providing training and continuous education in various fields of immunopathology. Aims and Mission Nowadays, immunopathology has become a multidisciplinary problem. The WIPO global mission is to promote through education and research activities worldwide: – basic and clinical research in experimental and clinical immunology, allergy and asthma, autoimmunity, immunodeficiency, AIDS, immunobiotechnology, – prevention and treatment of different manifestations of immunopathology—immune-associated disorders, – excellence in patient care in this very important area of medicine and to establish communication between specialists in various fields of medical science and practice. e We encourage to join WIPO national and regional societies as well as individual members—doctors -
ÖGAI Symposium 2015 50 Years of B-Lymphocytes
ÖGAI Symposium 2015 50 Years of B-Lymphocytes Delineation of the Thymic and Bursal Lymphoid Systems in the Chicken. Cooper, MD, Peterson RD, Good RA Pediatric Res.Lab. of the Variety Club Heart Hospital, Univ. of Minnesota, Minn., USA Nature, 1965, 205:143-6 December 11-12, 2015 College of Physicians in Vienna, Billrothhaus 1090 Vienna, Frankgasse 8 PROGRAMME ABSTRACTS Welcome Dear guests, dear colleagues and friends, We cordially welcome you to the symposium ‘50 Years of B-Lymphocytes’ which is organized by the Austrian Society for Allergology and Immunology, ÖGAI, in Vienna, from December 11-12, 2015. With this symposium we are celebrating the discovery of B-lymphocytes, which play a key role in the defense against pathogens, tumors, and environmental factors potentially harming human beings. The understanding of B lymphocytes and antibodies produced by these cells is also crucial for the understanding of the large variety of diseases such as allergies, autoimmune diseases, immunodeficiencies and other immune-mediated diseases. The symposium will take place in the historical building of the College of Physicians in Vienna, the Billroth-Haus. The program consists of plenary lectures, given by outstanding international scientists, selected oral presentations by members of the Austrian Society for Allergology and Immunology, ÖGAI, and five poster sessions, which offer early career scientists to present their cutting edge research. On the occasion of this meeting the Austrian Society for Allergology and Immunology is proud to award the Clemens von Pirquet medal to Prof. Gabriel Pauli from Strasbourg, France, and the Karl Landsteiner Medal to Prof. Lorenzo Moretta from Rome, Italy. -
Cv Prof. Yehuda Shoenfeld
1 CV YEHUDA SHOENFELD, M.D., FRCP (Hon.) .MaACR CURRICULUM VITAE 2 0 2 0 Chaim Sheba Medical Center The Zabludowicz Center for Autoimmune Diseases Tel Hashomer 5265601, Israel. Former Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Tel: 03-5308070 Fax: 03-5352855 Mobile: 052-6669020 Tel. Home: 03- 5344877 Home Address: 26 Sapir St. Ramat-Gan 5265601 E-mail: [email protected] 2 CURRICULUM VITAE YEHUDA SHOENFELD, M.D. Date and place of birth: February 14, 1948, Slovakia. Marital Status: Married to Irit + 3 (Nettea, Amir, Guy) EDUCATION AND APPOINTMENTS 1965 - 1972 Hadassah Medical School, Hebrew University, Jerusalem 1972 - M.D. Thesis: "Osteogenesis Imperfecta" (Advisor: Prof. A. Fried) cum laude 1976 - 1978 Diploma cum laude upon completion of post graduate studies in internal medicine, Postgraduate Medical School, Tel Aviv University 1976 - 1978 Senior resident, Department of Internal Medicine "D" and Out-Patient Clinic of Hematology and Immunology, Beilinson Medical Center, Petach Tikva, Israel 1978 (3m) - Clinical Fellowship, Hematology/Oncology, Department of Hematology, City of Hope, Duarte, California (Director: Prof. E. Beutler) 1979 (3m) - Clinical Fellowship Hematology/Oncology, Tufts New England Medical Center, Boston, Mass. (Director: Prof. Robert S. Schwartz) 1980 (3m) - Clinical Fellowship Hematology/Oncology, Cornell Medical Center, New York Hospital (Director: Prof. R. Nachman) 1980 - Master in Internal Medicine, Postgraduate -
Annual Report 2014
FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE ITEM PRE-CLINICAL PHARMACOLOGY > < TOXICOLOGY TESTING < MANUFACTURING OF BIOPHARMA- CEUTICALS FOR CLINICAL TRIALS < EARLY-PHASE CLINICAL TRIALS ENVIRONMENTAL, OCCUPATIONAL AND CONSUMER PROTECTION > REGISTRATION AND RISK ASSESSMENT > ANNUAL Report 2014 This Annual Report 2014 of the Fraunhofer ITEM gives an insight into the activities and service profiles of the institute’s six business units and provides examples of typical contract and pre-competitive research projects performed in each of these areas. The title page and also the opening pages of the different business units in this Annual Report show the business unit spokespersons, who represent, coordinate, and further develop the individual business units to meet market requirements. Business units of the Fraunhofer ITEM Pre-clinical Pharmacology Toxicology Testing Manufacturing of Biopharmaceuticals for Clinical Trials Early-Phase Clinical Trials Environmental, Occupational and Consumer Protection Registration and Risk Assessment FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMental MEDICINE ITEM PERFORMANCE AND RESultS ANNUAL REPORT 2014 Contents Foreword to readers 4 Business units of the Fraunhofer ITEM 20 Profile of the institute 6 Organizational structure 9 Business Unit Pre-clinical Pharmacology Competencies 10 Focus of activities in 2014 22 GXP – quality assurance according to international Projects 26 standards 12 Biofilms for testing of antibiotics 26 Staff and institute budget performance 14 Pre-clinical efficacy -
Drug “Allergy” Is No Allergy a View Back, with Some Surprising Conclusions
Drug “allergy” is no allergy a view back, with some surprising conclusions Werner J. Pichler, MD [email protected] [email protected] Division Allergology, Inselspital, ADR-AC GmbH University of Bern, Adverse Drug Reactions – CH 3010 Bern Analysis and Consulting Switzerland Holligenstr 91, CH 3008 Bern, Switzerland Drug allergy allergy an immune response to an innocous substance which leads to symptoms an immune response to a drug or drug- drug allergy metabolite which leads to clinical symptoms activation of innate and adaptive immunity, immune response stimulation of specific T-cells and specific antibodies, inflammatory reaction drug often < 1000 D; small molecules are per se not immunogenic, covalent binding to carrier protein (hapten-carrier complex) required for «immunogenicity» Adverse Drug Reaction (type B): Drug Allergy • anaphylaxis, urticaria • maculo-papular exanthema • bullous exanthema • acute generalized exanthematous pustulosis (AGEP) • Stevens-Johnson Syndrome (SJS) toxic-epidermal necrolysis (TEN) • DRESS, hepatitis , interstitial nephritis,pneumonitis • drug induced autoimmunity (SLE, pemphigus, ...) BIZARRE CLINIC PURPOSE OF IMMUNE REACTION ? How are drugs stimulating the immune system ? Hapten/prohapten specific immunity Penicillin G SMX-NO Haptens are chemically reactive R N H O compounds able to bind H H C N CH S O S 3 H2 covalently to proteins. CH N 3 I O ON a Adduct formation gives a danger N O N N O signal to APC (CD86 A upregulation, IL-1b-secretion) T E Adduct formation forms A neoantigenic determinants -
Wellcome Witnesses to Twentieth Century Medicine
WELLCOME WITNESSES TO TWENTIETH CENTURY MEDICINE _______________________________________________________________ TECHNOLOGY TRANSFER IN BRITAIN: THE CASE OF MONOCLONAL ANTIBODIES ______________________________________________ SELF AND NON-SELF: A HISTORY OF AUTOIMMUNITY ______________________ ENDOGENOUS OPIATES _____________________________________ THE COMMITTEE ON SAFETY OF DRUGS __________________________________ WITNESS SEMINAR TRANSCRIPTS EDITED BY: E M TANSEY P P CATTERALL D A CHRISTIE S V WILLHOFT L A REYNOLDS Volume One – April 1997 CONTENTS WHAT IS A WITNESS SEMINAR? i E M TANSEY TECHNOLOGY TRANSFER IN BRITAIN: THE CASE OF MONOCLONAL ANTIBODIES EDITORS: E M TANSEY AND P P CATTERALL TRANSCRIPT 1 INDEX 33 SELF AND NON-SELF: A HISTORY OF AUTOIMMUNITY EDITORS: E M TANSEY, S V WILLHOFT AND D A CHRISTIE TRANSCRIPT 35 INDEX 65 ENDOGENOUS OPIATES EDITORS: E M TANSEY AND D A CHRISTIE TRANSCRIPT 67 INDEX 100 THE COMMITTEE ON SAFETY OF DRUGS EDITORS: E M TANSEY AND L A REYNOLDS TRANSCRIPT 103 INDEX 133 WHAT IS A WITNESS SEMINAR? Advances in medical science and medical practice throughout the twentieth century, and especially after the Second World War, have proceeded at such a pace, and with such an intensity, that they provide new and genuine challenges to historians. Scientists and clinicians themselves frequently bemoan the rate at which published material proliferates in their disciplines, and the near impossibility of ‘keeping up with the literature’. Pity, then, the poor historian, trying to make sense of this mass of published data, scouring archives for unpublished accounts and illuminating details, and attempting throughout to comprehend, contextualize, reconstruct and convey to others the stories of the recent past and their significance. The extensive published record of modern medicine and medical science raises particular problems for historians: it is often presented in a piecemeal but formal fashion, sometimes seemingly designed to conceal rather than reveal the processes by which scientific medicine is conducted. -
President's Report 2018
VISION COUNTING UP TO 50 President's Report 2018 Chairman’s Message 4 President’s Message 5 Senior Administration 6 BGU by the Numbers 8 Building BGU 14 Innovation for the Startup Nation 16 New & Noteworthy 20 From BGU to the World 40 President's Report Alumni Community 42 2018 Campus Life 46 Community Outreach 52 Recognizing Our Friends 57 Honorary Degrees 88 Board of Governors 93 Associates Organizations 96 BGU Nation Celebrate BGU’s role in the Israeli miracle Nurturing the Negev 12 Forging the Hi-Tech Nation 18 A Passion for Research 24 Harnessing the Desert 30 Defending the Nation 36 The Beer-Sheva Spirit 44 Cultivating Israeli Society 50 Produced by the Department of Publications and Media Relations Osnat Eitan, Director In coordination with the Department of Donor and Associates Affairs Jill Ben-Dor, Director Editor Elana Chipman Editorial Staff Ehud Zion Waldoks, Jacqueline Watson-Alloun, Angie Zamir Production Noa Fisherman Photos Dani Machlis Concept and Design www.Image2u.co.il 4 President's Report 2018 Ben-Gurion University of the Negev - BGU Nation 5 From the From the Chairman President Israel’s first Prime Minister, David Ben–Gurion, said:“Only Apartments Program, it is worth noting that there are 73 This year we are celebrating Israel’s 70th anniversary and Program has been studied and reproduced around through a united effort by the State … by a people ready “Open Apartments” in Beer-Sheva’s neighborhoods, where acknowledging our contributions to the State of Israel, the the world and our students are an inspiration to their for a great voluntary effort, by a youth bold in spirit and students live and actively engage with the local community Negev, and the world, even as we count up to our own neighbors, encouraging them and helping them strive for a inspired by creative heroism, by scientists liberated from the through various cultural and educational activities. -
In Memoriam Professor De Weck
Letters to the Editor In Memoriam Professor De Weck The speciality of allergology recently suffered the loss of Professor Alain de Weck. For almost 30 years, Professor de Weck was the Director of the Institute of Clinical Immunology and Allergy at the University of Bern, Switzerland, where he started his research in immunopathology and the dynamics of hypersensitivity in drug allergy (penicillin), before moving on to study the immunological mechanisms of allergic reactions at the cellular level. His work was reÁ ected in major studies that generated more than 500 articles, as well as in several books and publications. The research led by Professor de Weck played a key role in promoting allergology throughout the world. Professor de Weck was also an energetic promoter of allergology as an academic discipline. retirement in 1993 and until 4 years ago, he devoted himself Professor de Weck devoted part of his time to international to research, together with my colleague Professor Sanz, with societies such as the International Union of Immunology whom he published more than 20 articles. His role as Associate Societies (IUIS) and the International Association of Editor at the Journal of Investigational Allergology and Clinical Allergology and Clinical Immunology (IAACI), both of Immunology was an enormous help to me. which he served as President. It was in the IAACI, of which Finally, I would like to highlight his generous and positive I was also President, where we began a friendship that lasted idea of combining his library of allergology and clinical almost 20 years. He was also a key member and president of immunology with mine to create a legacy that is now available the Collegium Internationale Allergologicum (CIA), which in the Library of the School of Medicine of the University of beneÀ ted greatly from his efforts. -
Immunology of the Allergic Response 1
9781405157209_4_001.qxd 4/1/08 20:03 Page 1 1 Immunology of the Allergic Response 9781405157209_4_001.qxd 4/1/08 20:03 Page 2 .. 9781405157209_4_001.qxd 4/1/08 20:03 Page 3 1 Allergy and Hypersensitivity: History and Concepts A. Barry Kay Summary The study of allergy (“allergology”) and hypersensitivity, and the associated allergic diseases, have their roots in the science of immunology but overlap with many disciplines including pharmacology, biochemistry, cell and molecular biology, and general pathology, particularly the study of inflammation. Allergic diseases involve many organs and tissues such as the upper and lower airways, the skin, and the gastrointestinal tract and therefore the history of relevant discoveries in the field are long and complex. This chapter gives only a brief account of the major milestones in the history of allergy and the concepts which have arisen from them. It deals mainly with discoveries in Fig. 1.1 A commemorative postage stamp to mark the discovery the 19th and early 20th century, particularly the events which of anaphylaxis by Charles R. Richet (1850–1935) and Paul J. Portier followed the description of anaphylaxis and culminated in the (1866–1962). discovery of IgE as the carrier of reaginic activity. An important conceptual landmark that coincided with the considerable foreign proteins to various species including dogs (Magendie increase in knowledge of immunologic aspects of hypersensitivity 1839), guinea pigs (Von Behring 1893, quoted in Becker 1999, was the Coombs and Gell classification of hypersensitivity p. 876) and rabbits (Flexner 1894, reviewed in Bulloch 1937). reactions in the 1960s. This classification is revisited and updated However it was not until the discovery of anaphylaxis by to take into account some newer finding on the initiation of the allergic response. -
Proceedings of the American Philosophical Society Vol. 120, Num
Proceedings of the American Philosophical Society Vol. 120, Num. 1. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Fred L. Whipple. “Comet Kohoutek in Retrospect” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 1-6 Myron P. Gilmore. “The Berensons and Villa I Tatti” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 7-12 Helen B. Taussig. “The Development of the Blalock-Taussing Operation and Its Results Twenty Years Later” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 13-20 Ward H. Goodenough. “On the Origin of Matrilineal Clans: A “Just So” Story” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 21-36 Leon N. Cooper. “How Possible Becomes Actual in the Quantum Theory” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 37-45 John Owen King. “Labors of the Estranged Personality: Josiah Royce on “The Case of John Bunyan”” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 46-58 Stanley A. Czarnik. “The Theory of the Mesolithic in European Archaeology” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 59-66 Proceedings of the American Philosophical Society Vol. 120, Num. 2. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Jonathan E. Rhoads. “New Approaches in the Study of Neoplasia: Preliminary Remarks for the Symposium” Proceedings of the American Philosophical Society. Vol. 120, Num. 2. Año 1976; pagina 67-68 Sol Spiegelman. “The Search for Viruses in Human Cancer” Proceedings of the American Philosophical Society.